{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T16:12:00Z","timestamp":1773850320985,"version":"3.50.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["americanjournalofsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Surgery"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.amjsurg.2020.11.012","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T12:40:57Z","timestamp":1604925657000},"page":"521-524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Contralateral breast cancer risk and endocrine therapy use in patients with ductal carcinoma in situ treated with unilateral mastectomy in the modern era"],"prefix":"10.1016","volume":"221","author":[{"given":"Ayat S.","family":"ElSherif","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8601-593X","authenticated-orcid":false,"given":"Stephanie A.","family":"Valente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.amjsurg.2020.11.012_bib1","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1200\/JCO.2008.20.1681","article-title":"Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ","volume":"27","author":"Tuttle","year":"2009","journal-title":"J\u00a0Clin Oncol: official journal of the American Society of Clinical Oncology"},{"issue":"10","key":"10.1016\/j.amjsurg.2020.11.012_bib2","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1245\/s10434-016-5443-5","article-title":"Contralateral prophylactic mastectomy (CPM) consensus statement from the American Society of Breast Surgeons: data on CPM outcomes and risks","volume":"23","author":"Boughey","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.amjsurg.2020.11.012_bib3","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0960-9776(03)00152-8","article-title":"The risk of a contralateral breast cancer among women diagnosed with ductal and lobular breast carcinoma in situ: data from the Connecticut Tumor Registry","volume":"12","author":"Claus","year":"2003","journal-title":"Breast"},{"issue":"3","key":"10.1016\/j.amjsurg.2020.11.012_bib4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10549-007-9807-1","article-title":"Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast","volume":"111","author":"Innos","year":"2008","journal-title":"Breast Canc Res Treat"},{"issue":"9169","key":"10.1016\/j.amjsurg.2020.11.012_bib5","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(99)05036-9","article-title":"Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial","volume":"353","author":"Fisher","year":"1999","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.amjsurg.2020.11.012_bib6","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1200\/JCO.2010.34.0141","article-title":"Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor\u2013positive ductal carcinoma in situ: a study based on NSABP protocol B-24","volume":"30","author":"Allred","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.amjsurg.2020.11.012_bib7","unstructured":"National comprehensive cancer Network breast cancer guidelines. https:\/\/wwwnccnorg\/professionals\/physician_gls\/defaultaspx. Version 6.2020."},{"issue":"10021","key":"10.1016\/j.amjsurg.2020.11.012_bib8","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(15)01169-1","article-title":"Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial","volume":"387","author":"Ganz","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.amjsurg.2020.11.012_bib9","first-page":"99","article-title":"Second cancer following cancer of the breast in Connecticut, 1935-82","volume":"68","author":"Harvey","year":"1985","journal-title":"Natl Canc Inst Monogr"},{"issue":"3","key":"10.1016\/j.amjsurg.2020.11.012_bib10","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s10549-018-4860-5","article-title":"Estrogen-receptor status and risk of contralateral breast cancer following DCIS","volume":"171","author":"Stout","year":"2018","journal-title":"Breast Canc Res Treat"},{"issue":"9","key":"10.1016\/j.amjsurg.2020.11.012_bib11","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1002\/cam4.2914","article-title":"Differences in physician opinions about controversial issues surrounding contralateral prophylactic mastectomy (CPM): a survey of physicians from accredited breast centers in the United States","volume":"9","author":"Yao","year":"2020","journal-title":"Cancer Medicine"},{"issue":"4","key":"10.1016\/j.amjsurg.2020.11.012_bib12","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0360-3016(03)00203-7","article-title":"Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study","volume":"56","author":"Gao","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.amjsurg.2020.11.012_bib13","first-page":"2104","article-title":"Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ","volume":"106","author":"Li","year":"2006","journal-title":"1988-2001. Cancer"}],"container-title":["The American Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961020307352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961020307352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:20:25Z","timestamp":1757701225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002961020307352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0002961020307352"],"URL":"https:\/\/doi.org\/10.1016\/j.amjsurg.2020.11.012","relation":{},"ISSN":["0002-9610"],"issn-type":[{"value":"0002-9610","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contralateral breast cancer risk and endocrine therapy use in patients with ductal carcinoma in situ treated with unilateral mastectomy in the modern era","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjsurg.2020.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}